Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Atypical kinase COQ8A, mitochondrial, is an enzyme critical for the biosynthesis of coenzyme Q10 (ubiquinone), which plays an essential role in mitochondrial oxidative phosphorylation by facilitating electron transport and ATP production. The COQ8A protein exhibits kinase activity, likely acting as a lipid or small molecule kinase within the mitochondrial inner membrane—though precise substrate specificity remains under investigation. It shows chaperone-like activity necessary for assembly and function of the coenzyme Q synthome. Genetic mutations disrupting COQ8A function can result in primary coenzyme Q10 deficiency, manifesting primarily as neurodegenerative disorders (notably cerebellar ataxia), myopathy, and kidney disease due to impaired energy production and increased oxidative stress. Coenzyme Q10 supplementation can rescue mitochondrial function in COQ8A deficiency, highlighting its essential role in cellular metabolism and suggesting potential avenues for therapy.
Restoration of mitochondrial electron transport via ubiquinone biosynthesis/complex formation, antioxidant protection (for CoQ10 supplementation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Atypical kinase COQ8A, mitochondrial (COQ8A).